Form 4: Myriad Genetics Executive Kevin Richard Haas Reports Stock Disposals for Tax Obligations

Kevin Richard Haas, Chief Technology Officer of Myriad Genetics, reported disposing of shares to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Kevin Richard Haas, the Chief Technology Officer of Myriad Genetics Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• On March 22 and 24, 2024, Haas disposed of shares of common stock to satisfy tax withholding obligations related to the vesting of restricted stock units and performance-based restricted stock units.
• A total of 1,685 shares were disposed of on March 22, 2024, and 1,172 and 1,718 shares were disposed of on March 24, 2024, all at a price of $22.24 per share.
• Following these transactions, Haas beneficially owns 132,097 shares of Myriad Genetics Inc.

Sentiment

Score: 5

Explanation: This is a neutral event. It reflects routine tax-related stock disposals and doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The disposal of shares by an executive could be perceived neutrally by shareholders, as it is related to tax obligations and not necessarily a reflection of the executive's view on the company's future performance.

Key Dates